| abstract |
An object of the present invention is to provide a therapeutic and/or prophylactic agent for adult T cell leukemia lymphoma comprising a compound having a specific chemical structure or a pharmaceutically acceptable salt thereof.nThe solution is a therapeutic and/or prophylactic agent for adult T-cell leukemia lymphoma, which is 7-chloro-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6) - dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxan-5-carbamide or a pharmaceutically acceptable salt thereof, or 7-bromo-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1) , 2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxin-5-carboxamide or a pharmaceutically acceptable salt thereof as an active ingredient. |